Psychiatry

Research breakthroughs, clinical innovations, and other news

COVID-19: Coping and Resiliency Skills

COVID-19: Coping and Resiliency Skills

As the outbreak of COVID-19 spreads throughout the greater New York area, people are adjusting to radical changes in their daily life. Businesses are closed, people are working from home—if they are able to work at all—and kids are trying to learn at home. It’s a...

read more
Five Things to Know About Esketamine

Five Things to Know About Esketamine

In March 2019, intranasal esketamine—a form of ketamine marketed as SPRAVATO™ CIII Nasal Spray*—was approved by the U.S. Food and Drug Administration (FDA) to treat patients with treatment-resistant depression (TRD). James Murrough, MD, PhD, Director of Mount Sinai’s...

read more
Inventing New Ways to Deliver Mental Health Care to the Community

Inventing New Ways to Deliver Mental Health Care to the Community

As part of the state’s ongoing effort to further innovate in behavioral health care and develop more effective alternatives to emergency rooms, the New York State Office of Mental Health (OMH) asked Mount Sinai Morningside (formerly known as Mount Sinai St. Luke’s) to...

read more
What Are the Benefits of CBD?

What Are the Benefits of CBD?

Interest in cannabidiol (CBD) has increased dramatically in recent years. Available in oils, lotions, and vaping fluid, the substance has been touted as a cure-all for various ailments including anxiety, arthritis, and insomnia. While its growing reputation is...

read more

Pin It on Pinterest

Share This

Share this post with your friends!

Share This

Share this post with your friends!